Login to Your Account


Eyes on the prize

NEW YORK – Despite the appeal of shorter development timelines – and the potential of a multibillion-dollar market – ophthalmology drug development has lagged behind work in other disease areas in terms of new targets, biomarker development and even the number of players operating in the space.

more »


Our Habitat for All Things Science
AAAS 2016: Newly developed mini brains could dramatically alter drug discovery
Opinion


Partners in Focus